Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) Return on Capital Employed (2024 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Return on Capital Employed for 2 consecutive years, with 0.71% as the latest value for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 38.0% year-over-year to 0.71%; the TTM value through Dec 2025 reached 0.71%, down 38.0%, while the annual FY2025 figure was 0.57%, 11.0% down from the prior year.
  • Return on Capital Employed hit 0.71% in Q4 2025 for Artiva Biotherapeutics, down from 0.58% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.26% in Q3 2024 and bottomed at 0.71% in Q4 2025.